30 results
DEFM14A
APGN
Apexigen Inc
30 Jun 23
Proxy related to merger
4:21pm
plan for healthcare providers, and/or other elements, such as boxed warning on the packaging, to assure safe use;
Apexigen could be sued and held … for manufacturing, labeling, packaging, storage, advertising, promotion, sampling, record-keeping, conduct of post-marketing studies, and submission of safety
425
PYXS
Pyxis Oncology Inc
24 May 23
Business combination disclosure
7:05am
Authorities”) necessary for the development, testing, manufacturing, packaging, labeling, distribution, promotion, storage, sale, marketing, import
8-K
EX-2.1
APGN
Apexigen Inc
24 May 23
Pyxis Oncology to Acquire Apexigen
7:02am
Authorities”) necessary for the development, testing, manufacturing, packaging, labeling, distribution, promotion, storage, sale, marketing, import, export
424B3
8vsaq gar2dluryrgt21
10 Apr 23
Prospectus supplement
4:03pm
424B3
r9fd2
10 Apr 23
Prospectus supplement
4:02pm
POS AM
76pn nd7gg
4 Apr 23
Prospectus update (post-effective amendment)
4:24pm
POS AM
39rtc5wuo5rfw3r 84
4 Apr 23
Prospectus update (post-effective amendment)
4:23pm
424B3
v2c99oyymz9qce
9 Sep 22
Prospectus supplement
4:40pm
424B3
h6g tiyr3
9 Sep 22
Prospectus supplement
4:38pm
424B3
hqzzb
6 Jul 22
Prospectus supplement
4:18pm